Evidence map›Paper›PMID 41863593›Full record

ArticleEmerging infectious diseases2026

Costs of Extrapulmonary Nontuberculous Mycobacteria Disease, Denmark, 2005-2017.

Victor Naestholt Dahl, Andreas Arnholdt Pedersen, Michael Høffding Ibsen, Ole Hilberg, Anders Løkke, Andreas Fløe

Abstract readHistorical Article
In one paragraph

Article in Emerging infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Victor Naestholt Dahl
Andreas Arnholdt Pedersen
Michael Høffding Ibsen
Ole Hilberg
Anders Løkke
Andreas Fløe

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We estimated the direct and indirect costs associated with extrapulmonary nontuberculous mycobacteria (ENTM) disease in Denmark during 2005-2017. ENTM disease was associated with substantially higher healthcare costs, lower employment income, and increased public benefits before, around, and after diagnosis. Our findings highlight the substantial socioeconomic burden associated with ENTM disease.

Indexed as

Cost of IllnessHealth Care CostsMycobacterium Infections, NontuberculousNontuberculous MycobacteriaDenmarkHistory, 21st CenturyHumansbacteriacost analysisDenmarkextrapulmonaryhealthcare economicsnontuberculous mycobacteriapsychosocial supportpublic healthrespiratory infectionstuberculosis and other mycobacteria

Identifiers

PMID41863593
PMCPMC13016030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.